New generations of hematology analyzers produce fast and reliable data on blood count, while at the same time offering screening information on differential blood count.
Each of 269 samples was classified as truly negative (TN), denoting a differential blood count within the reference range by both methods; truly positive (TP), denoting a differential blood count signalized by the analyzer as pathologic, which was confirmed by manual differentiation; falsely positive (FP), denoting a result signalized by the analyzer as pathologic, whereas on manual differentiation it showed no deviations from a sample of a healthy subject; and falsely negative (FN), denoting a differential blood count result that the analyzer failed to signalize as pathologic, whereas on manual differentiation the sample was found to be pathologic.
In these cases, a differential blood count obtained by the analyzer produced suspect population flags, whereas on manual differentiation it showed no deviation from a sample of a healthy subject.
Nevertheless, the usefulness of the differential blood count obtained by the analyzer is limited in cases of acute infective processes, hematologic diseases, and allergic states accompanied by changes in hematologic parameters.
in category 3 or 4), regardless of the risk factor working environment ECG, laboratory blood tests (erythrocyte sedimentation rate , differential blood count
and budget, glucose, total cholesterol, HDL, LDL, Triglycerides, uric acid, urea, blood creatinine, AST, ALT, ALP, total bilirubin, CA 125 tumor markers, tumor markers PSA, chemically urine, stool for occult blood ), abdominal ultrasound, and ophthalmologic examination.